Obesity
Conditions
Brief summary
The study was aimed at investigating the relationship between hormone parameters and urinary aldosterone levels in 24h within a cohort of overweight and obesity.
Detailed description
Subjects were enrolled at the first examination whether they were not taking any medication, including oral contraceptives or drugs for osteoporosis, and free of significant medical illnesses, except obesity. Exclusion criteria were history of endocrinological diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.), chronic inflammatory diseases, stable known hypertension, angina pectoris, stroke, transient ischemic attack, heart infarction, congenital heart disease, malignancies, chronic inflammatory diseases, renal and liver failure, angina pectoris, myocardial infarction, heart failure, congenital heart diseases, minor and major stroke, and inherited thrombocytopenias and other major malignancies. Subjects were examined by means of the medical history, hormonal, metabolic and routine hematochemical parameters. The investigators provided for a clinical baseline evaluation that included extemporaneous ambulatory blood pressure (BP) and a physical assessment of body weight, Body Mass Index (BMI) and Waist Circumference (WC) as anthropometric parameters.
Interventions
OTHERObservational
Observational
Sponsors
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Inclusion criteria
* Overweight or obesity (BMI\> 25 Kg/m2)
Exclusion criteria
* Any kind of drug * Hypertension * Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.), * Chronic inflammatory diseases * Renal failure * Liver failure * Angina pectoris * Myocardial infarction and heart failure * Genetic heart diseases * Thrombocytopenias
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Thyroid hormones (FT3, FT4) | Baseline | FT3 (pg/mL), FT4 (pg/mL) concentration in serum |
| TSH | Baseline | TSH (mU/L) concentration in serum |
| Urinary Aldosterone | Baseline | 24-h Urine Aldosterone (mg/24 h) |
| Prolactin | Baseline | Prolactin (ng/ml) concentration in serum |
| Insulin | Baseline | Insulin (mIU/L) concentration in serum |
| Parathyroid Hormone | Baseline | PTH (pg/mL) concentration in serum |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Total cholesterol | Baseline | Total cholesterol (mg/dL) concentrations in serum |
| Vitamin D | Baseline | Vitamin D (ng/mL) concentration in serum |
| HDL cholesterol | Baseline | HDL cholesterol (mg/dL) concentrations in serum |
| LDL cholesterol | Baseline | LDL cholesterol (mg/dL) concentrations in serum |
| BMI | Baseline | BMI (kg/m\^2) |
| Height | Baseline | Height in meters |
| Weight | Baseline | Weight in kilograms |
Countries
Italy
Outcome results
None listed